Shares of AdvanSix Inc (NYSE:ASIX) have received a consensus broker rating score of 2.00 (Buy) from the two brokers that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company.
Brokerages have set a one year consensus target price of $33.50 for the company and are forecasting that the company will post $0.39 EPS for the current quarter, according to Zacks. Zacks has also assigned AdvanSix an industry rank of 101 out of 256 based on the ratings given to related companies.
A number of brokerages have recently commented on ASIX. Zacks Investment Research cut shares of AdvanSix from a “hold” rating to a “strong sell” rating in a research note on Wednesday. ValuEngine cut shares of AdvanSix from a “hold” rating to a “sell” rating in a research note on Friday, May 24th.
A number of institutional investors and hedge funds have recently made changes to their positions in ASIX. Dimensional Fund Advisors LP raised its holdings in shares of AdvanSix by 3.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 943,169 shares of the company’s stock worth $22,957,000 after acquiring an additional 35,803 shares during the period. D. E. Shaw & Co. Inc. raised its holdings in shares of AdvanSix by 14.1% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 768,409 shares of the company’s stock worth $18,704,000 after acquiring an additional 94,694 shares during the period. Norges Bank purchased a new position in shares of AdvanSix during the 4th quarter worth $16,966,000. Geode Capital Management LLC raised its holdings in shares of AdvanSix by 5.9% during the 4th quarter. Geode Capital Management LLC now owns 318,348 shares of the company’s stock worth $7,748,000 after acquiring an additional 17,718 shares during the period. Finally, Deutsche Bank AG raised its holdings in shares of AdvanSix by 133.8% during the 4th quarter. Deutsche Bank AG now owns 154,528 shares of the company’s stock worth $3,755,000 after acquiring an additional 88,429 shares during the period. 83.09% of the stock is currently owned by institutional investors.
ASIX traded up $0.52 during trading on Thursday, reaching $24.22. 166,016 shares of the company’s stock were exchanged, compared to its average volume of 163,341. AdvanSix has a 1 year low of $22.57 and a 1 year high of $41.45. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.05 and a quick ratio of 0.50. The stock has a market capitalization of $672.13 million, a PE ratio of 11.59 and a beta of 2.09. The stock has a fifty day moving average of $26.52.
AdvanSix (NYSE:ASIX) last posted its quarterly earnings results on Friday, May 3rd. The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.29. AdvanSix had a net margin of 5.09% and a return on equity of 17.96%. The company had revenue of $314.90 million during the quarter, compared to analyst estimates of $340.87 million. During the same period last year, the firm posted $0.37 EPS. AdvanSix’s revenue for the quarter was down 12.3% compared to the same quarter last year. As a group, analysts predict that AdvanSix will post 2.25 earnings per share for the current fiscal year.
AdvanSix Company Profile
AdvanSix Inc manufactures and sells polymer resins. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce engineered plastics, fibers, filaments, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone, which is used by customers in the production of adhesives, paints, coatings, solvents, herbicides, and other engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, cyclohexanol, acetaldehyde oxime, 2-pentanone oxime, sulfuric acid, ammonia, and carbon dioxide.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.